Access the full text.
Sign up today, get DeepDyve free for 14 days.
S. Krishnan, L. Dawson, J. Seong, Y. Akine, S. Beddar, T. Briere, C. Crane, F. Mornex (2008)Radiotherapy for Hepatocellular Carcinoma: An Overview
Annals of Surgical Oncology, 15
D. Parkin, F. Bray, J. Ferlay, P. Pisani (2005)Global Cancer Statistics, 2002
CA: A Cancer Journal for Clinicians, 55
A. Jemal, F. Bray, Melissa Center, J. Ferlay, Elizabeth Ward, David Forman (2011)Global Cancer Statistics
N. Kothary, J. Weintraub, J. Susman, J. Rundback (2007)Transarterial chemoembolization for primary hepatocellular carcinoma in patients at high risk.
Journal of vascular and interventional radiology : JVIR, 18 12
P. Farazi, R. DePinho (2006)Hepatocellular carcinoma pathogenesis: from genes to environment
Nature Reviews Cancer, 6
K. Izaki, K. Sugimoto, K. Sugimura, S. Hirota (2004)Transcatheter arterial embolization for advanced tumor thrombus with marked arterioportal or arteriovenous shunt complicating hepatocellular carcinoma.
Radiation medicine, 22 3
M. Facciuto, Manoj Singh, C. Rochon, J. Sharma, C. Gimenez, Umadevi Katta, C. Moorthy, S. Bentley-Hibbert, M. Rodriguez-Davalos, D. Wolf (2012)Stereotactic body radiation therapy in hepatocellular carcinoma and cirrhosis: Evaluation of radiological and pathological response
Journal of Surgical Oncology, 105
S. Sawrie, J. Fiveash, J. Caudell (2010)Stereotactic body radiation therapy for liver metastases and primary hepatocellular carcinoma: normal tissue tolerances and toxicity.
Cancer control : journal of the Moffitt Cancer Center, 17 2
J. Llovet (2005)Updated treatment approach to hepatocellular carcinoma
Journal of Gastroenterology, 40
T. Price, Susan Perkins, K. Sandrasegaran, M. Henderson, M. Maluccio, J. Zook, A. Tector, Rodrigo Vianna, P. Johnstone, H. Cárdenes (2012)Evaluation of response after stereotactic body radiotherapy for hepatocellular carcinoma
Ming Zhao, Jian-peng Wang, Wang Li, Zilin Huang, Fu-jun Zhang, W. Fan, Liang Zhang, Xishan Li, Chang-chuan Pan, Pei-Hong Wu (2011)[Comparison of safety and efficacy for transcatheter arterial chemoembolization alone and plus radiofrequency ablation in the treatment of single branch portal vein tumor thrombus of hepatocellular carcinoma and their prognosis factors].
Zhonghua yi xue za zhi, 91 17
Li (2009)Interventional chemoembolization combined with proton radiotherapy for the treatment of hepatocellular carcinoma accompanied with portal cancerous thrombus
J Intervent Radiol, 18
G. Cabibbo, M. Enea, M. Attanasio, J. Bruix, A. Craxì, C. Cammà (2010)A meta‐analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma
L. Dawson, C. Eccles, T. Craig (2006)Individualized image guided iso-NTCP based liver cancer SBRT
Acta Oncologica, 45
Y. Chung, I. Song, B. Song, G. Lee, M. Koh, Hyum‐Ki Yoon, Y. Lee, K. Sung, D. Suh (2000)Combined therapy consisting of intraarterial cisplatin infusion and systemic interferon‐α for hepatocellular carcinoma patients with major portal vein thrombosis or distant metastasis
Ren (2006)Stereotactic radiotherapy for hepatocellular carcinoma with portal tumor thrombi
Chin J Hepatol, 14
Benjamin Ren, Jiangyuan Song, Xiao-Dong Wang, H. Si, Y. Liao, Fengxiang Zhang, Zi-xia Zhang (2006)[Stereotactic radiotherapy for hepatocellular carcinoma with portal tumor thrombi].
Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 14 4
R. Tse, M. Hawkins, G. Lockwood, John Kim, B. Cummings, J. Knox, M. Sherman, L. Dawson (2008)Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 4
Hwai Yang, Sheng-Nan Lu, Y. Liaw, S. You, Chien‐An Sun, Li‐Yu Wang, C. Hsiao, Pei‐Jer Chen, Ding‐Shinn Chen, Chien-Jen Chen (2002)Hepatitis B e antigen and the risk of hepatocellular carcinoma.
The New England journal of medicine, 347 3
Li Ming-yue (2010)Body gamma knife and high intensity focused ultrasound (HIFU) for the treatment of portal vein tumor thrombosis of hepatocellular carcinoma
Journal of Modern Oncology
J. Seong, H. Park, K. Han, C. Chon, S. Chu, G. Kim, C. Suh (2003)Clinical results of 3-dimensional conformal radiotherapy combined with transarterial chemoembolization for hepatocellular carcinoma in the cirrhotic patients.
Hepatology research : the official journal of the Japan Society of Hepatology, 27 1
S. Obi, H. Yoshida, Risa Toune, T. Unuma, M. Kanda, Shin'pei Sato, R. Tateishi, T. Teratani, S. Shiina, M. Omata (2006)Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion
J. Kim, H. Yoon, Seong Kim, Kang Kim, G. Ko, Dong Gwon, K. Sung (2009)Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis
Alimentary Pharmacology & Therapeutics, 29
T. Lawrence, J. Robertson, M. Anscher, R. Jirtle, W. Ensminger, L. Fajardo (1995)Hepatic toxicity resulting from cancer treatment.
International journal of radiation oncology, biology, physics, 31 5
S. Lo, L. Dawson, Edward Kim, N. Mayr, Jian Wang, Zhibin Huang, H. Cárdenes (2010)Stereotactic body radiation therapy for hepatocellular carcinoma.
Discovery medicine, 9 48
B. Choi, I. Choi, H. Jang, Y. Kang, Jisun Jang, S. Bae, S. Yoon, G. Chai, K. Kang (2008)Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
BMC Cancer, 8
B. Emami, J. Lyman, A. Brown, L. Coia, M. Goitein, J. Munzenrider, B. Shank, L. Solin, M. Wesson (1991)Tolerance of normal tissue to therapeutic irradiation.
International journal of radiation oncology, biology, physics, 21 1
The purpose of this study was to evaluate the clinical efficacy, toxicity and adverse effects of stereotactic body radiotherapy (SBRT) combined with transarterial chemoembolization (TACE) in patients with advanced hepatocellular carcinoma (HCC) with portal vein tumor thrombosis (PVTT). A total of 101 patients diagnosed with primary HCC with PVTT were enrolled in this study and were randomly divided into three groups as follows: group A, 34 patients treated with γ‑SBRT followed by TACE; group B, 37 patients treated with TACE followed by γ‑SBRT; and group C, 30 patients treated with γ‑SBRT alone. The effective response rate for the entire patient sample was 87.1% (88/101) following a 3‑month treatment. The differences in the response rate, survival rate, α‑fetoprotein level restoration rate and rate of improvement of abdominal distention and discomfort between groups A and B were not statistically significant (P>0.05). However, the rates of groups A and B were higher compared to those of group C (P<0.05). The exacerbation rate of liver function in group A was lower compared to that in group B (P<0.05), although it exhibited no statistically significant difference from that in group C (P>0.05). No severe radiation‑related complications were reported during the follow‑up period. The combination of γ‑SBRT and TACE was shown to be a relatively effective local treatment for primary HCC patients with PVTT. Compared to γ‑SBRT followed by TACE and γ‑SBRT alone, TACE followed by γ‑SBRT may exert a negative effect on liver function. These results suggested that the combination of TACE and γ‑SBRT may be considered a relatively effective, safe and feasible treatment method for primary HCC patients with PVTT, although TACE followed by γ‑SBRT may negatively affect liver function.
Molecular and Clinical Oncology – Spandidos Publications
Published: Jan 1, 2014
Access the full text.
Sign up today, get DeepDyve free for 14 days.